XML 38 R53.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE 13 SIGNIFICANT AGREEMENTS (Details Narrative) (USD $)
12 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Jun. 30, 2011
UpfrontLicenseFeeMember
Dec. 31, 2010
Sale of rights to royalties on sales of Retin-A Micro® and Carac®
Dec. 31, 2007
Sale of rights to royalties on sales of Retin-A Micro® and Carac®
Dec. 31, 2006
Sale of rights to royalties on sales of Retin-A Micro® and Carac®
Revenue related to development services    $ 600,000 $ 1,300,000 $ 100,000      
Revenue from sale             30,000,000
Proceeds         $ 2,500,000 $ 2,500,000 $ 25,000,000